pill-icon-white

Clinically substantiated at
400mg / day

clock-icon-white

24-hour circulation allows for once
daily dose (Gota et al)

95x more bioavailable than standard 95% curcumin extract using AUC 67x using Cmax & 285x using AUC normalized

research-icon-white

We have 30 published clinical studies with
multiple already on the way

longvida-optimized-curcumin-logo-with-tag

Longvida® Optimized Curcumin® was designed by university neuroscientists to bypass initial hydrolysis and deliver bioefficacious levels of unglucuronidated (free) curcumin to the brain and throughout the entire body.

Exclusively licensed to Verdure Sciences®, patented Solid Lipid Curcumin Particle (SLCP) Technology enables the uptake of free curcumin to the blood and target tissues. Extensively studied by independent researchers globally, Longvida® Optimized Curcumin® is able to cross the blood-brain barrier, offering efficacious amounts of free curcumin at easily managed daily doses.

Multiple clinical findings show that Longvida® Optimized Curcumin® delivers free curcumin to target tissues. Studied extensively by independent academic and medical centers globally, Longvida® offers a 7.5 hour half-life, compared to the 2-3 hour half-life of standard curcumin.

CONTACT US ABOUT LONGVIDA
longvida-optimized-curcumin-logo-with-tag

Longvida® Optimized Curcumin® was designed by university neuroscientists to bypass initial hydrolysis and deliver bioefficacious levels of unglucuronidated (free) curcumin to the brain and throughout the entire body.

Exclusively licensed to Verdure Sciences®, patented Solid Lipid Curcumin Particle (SLCP) Technology enables the uptake of free curcumin to the blood and target tissues. Extensively studied by independent researchers globally, Longvida® Optimized Curcumin® is able to cross the blood-brain barrier, offering efficacious amounts of free curcumin at easily managed daily doses.

Multiple clinical findings show that Longvida® Optimized Curcumin® delivers free curcumin to target tissues. Studied extensively by independent academic and medical centers globally, Longvida® offers a 7.5 hour half-life, compared to the 2-3 hour half-life of standard curcumin.

CONTACT US ABOUT LONGVIDA
standard-icon-white

Non-GMO compliant; meets or exceeds
USP / ICH / Prop-65 standards.

toxicology-icon-white

Acute & subacute toxicology
data published.

self-gras-icon-white

Self-GRAS
Determination

patent-icon-white

US Patent 9192644, EP Patent 1993365.
Additional patents pending.

pill-icon-white

Clinically substantiated at
400mg / day

clock-icon-white

24-hour circulation allows for once
daily dose (Gota et al)

95x more bioavailable than standard 95% curcumin extract using AUC 67x using Cmax & 285x using AUC normalized

research-icon-white

We have 30 published clinical studies with
multiple already on the way

RESEARCH BEHIND LONGVIDA®

Recently published human clinical – positive effects using Longvida®

Researchers with the University of Colorado clinically investigated Longvida’s ability to improve vascular endothelial function, as assessed by endothelium dependent dilation (EDD), in middle-aged and older adults. After 12 weeks of 2000mg per day of Longvida® Optimized Curcumin®, brachial artery flow-mediated dilation (FMDba) was increased by 36% versus placebo, which showed no change. Results, published in January 2017, indicate that Longvida® improves vascular endothelial function by increasing nitric oxide bioavailability through a reduction in oxidative stress and inflammatory signaling in middle-aged and older adults. According to the authors, these results support evidence that supplementation of Longvida® may be a promising therapeutic option to improve vascular health. Further, this clinical provides additional support for Longvida’s efficacious ability to promote healthy aging.

LEARN MORE

From the farm to standardized extract, each part of the process is met with strict quality assurance and control parameters with traceability and sustainability measures held in high esteem to ensure consistency for the global market through our Verdugration™ initiative. Longvida® is supported with an extensive traceability and sustainability initiatives farmed and harvested by experienced farmers. Longvida’s turmeric supports these established relationships with a focus on ethics and quality standards.

LEARN MORE ABOUT VERDUGRATION

Longvida® has received recognition for the rigorous scientific support and proven efficacy as an optimized curcumin extract that delivers beneficial support for a wide variety of tangible health applications. It has earned multiple industry awards and global accreditation for groundbreaking research initiatives including receiving the NutraIngredients University Research of the Year Award in 2015, recognition as the NutraIngredients Nutrition Research Project of the Year Finalist 2018 and receiving the NutraIngredients Nutrition Research Project of the Year Award in 2019. Longvida® is also batch-verified for sports banned substances by Korva Labs, is non-GMO Project Verified, and Certified Glyphosate Residue Free.

Longvida® Optimized Curcumin® was designed by university neuroscientists to survive initial digestion and deliver free curcumin and metabolites to the brain and throughout the body using Solid Lipid Curcumin Particle (SLCP) Technology. SLCP enables the uptake of free curcumin to the blood and target tissues; inspired by traditional use. Extensively studied by independent researchers globally, Longvida® Optimized Curcumin® is able to cross the blood brain and blood retinal barriers, offering efficacious free curcumin at easily managed daily doses.

LEARN MORE ABOUT THE TECHNOLOGY

For nearly 15 years, Longvida® has been the safe, efficacious, clinically supported Cognitive Curcumin of Choice. Accredited by university researchers, and backed by more than 30 human clinical studies, Longvida® is well-established as a globally accepted curcumin with a long-standing history of efficacy, safety, and trust. In addition to efforts to exceed global regulatory compliance, Longvida® Optimized Curcumin® and SLCP Technology are protected by global intellectual property and multiple patents.

SEE THE RESEARCH BEHIND LONGVIDA

RESEARCH BEHIND LONGVIDA®

Recently published human clinical – positive effects using Longvida®

Researchers with the University of Colorado clinically investigated Longvida’s ability to improve vascular endothelial function, as assessed by endothelium dependent dilation (EDD), in middle-aged and older adults. After 12 weeks of 2000mg per day of Longvida® Optimized Curcumin®, brachial artery flow-mediated dilation (FMDba) was increased by 36% versus placebo, which showed no change. Results, published in January 2017, indicate that Longvida® improves vascular endothelial function by increasing nitric oxide bioavailability through a reduction in oxidative stress and inflammatory signaling in middle-aged and older adults. According to the authors, these results support evidence that supplementation of Longvida® may be a promising therapeutic option to improve vascular health. Further, this clinical provides additional support for Longvida’s efficacious ability to promote healthy aging.

LEARN MORE

Ready to learn more about Longvida® Optimized Curcumin®?

Contact Us